Product Highlight - FluMist

11 Sep 2025
Product Highlight - FluMist
Active ingredient: Live attenuated flu vaccine (A/H1N1, A/H3N2, B/Victoria lineage)

Indications: Active immunization in patients 2-49 yr for flu prevention caused by flu virus subtypes A & type B contained in the vaccine.

Dosage & Administration: Intranasal Administer as 0.1 mL/nostril. For children aged 2-8 years: 2 doses (0.2 mL each, administer as 0.1 mL per nostril) administer at least 1 month apart. For individual aged 9-49 years: 1 dose (0.2 mL each, administer as 0.1 mL per nostril).

The composition of the vaccine strains will be updated based on the recommendations of the World Health Organization (WHO).

AstraZeneca (Thailand) Ltd

19 Fl, Asia Centre Bldg, 173/20 South Sathorn Rd,
Thungmahamek, Sathorn, Bangkok 10120
Tel: (+66) 2739 7400 • Fax: (+66) 2739 7498
Website: www.astrazeneca.co.th

Related MIMS Drugs